ACARIX — Acarix AB Share News
0.000.00%
Last trade - 00:00- SEK236.94m
- SEK208.05m
- SEK7.36m
Brief: Acarix Q4 Gross Margin 80.3%
Brief: Acarix Carries Out Directed Share Issue
Brief: Acarix Raises SEK 32.7 Mln Before Costs Through Rights Issue
Brief: Acarix Enters Deal With External Investor On Top Guarantee Of SEK 1 Mln
Brief: Acarix Receives First CADScor System Order In Texas
Brief: Acarix Receives Additional Orders Of CADScor System In U.S.
Brief: Acarix Resolves On Partially Guaranteed Rights Issue Of SEK 53 Mln
Brief: Acarix Q3 Pre Tax Loss Widens To SEK 21.1 Mln
Brief: Acarix And The American College Of Cardiology Announce Strategic Collaboration
Brief: Acarix Q2 Loss Before Tax At SEK 18.4 Mln
Brief: Acarix Partners With Strategic Health AK
Brief: Acarix Signs Commercial Agreement In U.S., Gets Order In Louisiana
Brief: Acarix Signs Additional Commercial Agreement In US And Receives Rapid Orders In Both Mississippi And Tennessee
Brief: Acarix Q1 Revenues Up At SEK 1.3 Mln
Brief: Acarix Q1 Revenues Rises To SEK 1.3 Mln
Brief: FDA Requests Supplementary Information For Acarix Breakthrough Designation Request For Heart Failure Diagnosis
Brief: Acarix Gets Strategic Order In The U.S.
Brief: Acarix Appoints Helen Ljungdahl As New cEO
Brief: Acarix Announce Final Outcome In Rights Issue